| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Jul 06, 2026 |
ASML Holding NV - New York Shares
ASML
|
BUY |
$2,623.00
Est. +48%
|
$1,769.32 | $1,868.60 |
Pending
|
$1,801.86
+1.8%
|
| Jun 17, 2026 |
Arm Holdings plc. - ADR
ARM
|
BUY |
$500.00
Est. +18%
|
$424.16 | $452.61 |
Pending
|
$283.40
-33.2%
|
| Jun 10, 2026 |
Nuvalent Inc - Ordinary Shares - Class A
NUVL
|
BUY |
$124.00
Est. +1%
|
$123.25 | $123.99 |
Bullseye Hit (±1%)
|
$123.96
+0.6%
|
| Jun 09, 2026 |
Nurix Therapeutics Inc
NRIX
|
BUY |
$23.00
Est. +53%
|
$15.07 | $25.15 |
Target Met
|
$23.60
+56.6%
|
| May 18, 2026 |
Arm Holdings plc. - ADR
ARM
|
BUY |
$300.00
Est. +43%
|
$209.16 | $452.61 |
Target Met
|
$283.40
+35.5%
|
| Mar 13, 2026 |
Kura Oncology Inc
KURA
|
BUY |
$15.00
Est. +74%
|
$8.60 | $12.22 |
Pending
|
$10.54
+22.6%
|
| Jan 29, 2026 |
ASML Holding NV - New York Shares
ASML
|
BUY |
$1,911.00
Est. +34%
|
$1,422.92 | $1,999.90 |
Target Met
|
$1,801.86
+26.6%
|
| Jan 22, 2026 |
ASML Holding NV - New York Shares
ASML
|
BUY |
$1,642.00
Est. +21%
|
$1,360.09 | $1,999.90 |
Target Met
|
$1,801.86
+32.5%
|
| Dec 02, 2025 |
Janux Therapeutics Inc
JANX
|
BUY |
$57.00
Est. +230%
|
$17.28 | $18.86 |
Pending
|
$15.62
-9.6%
|
| Oct 31, 2025 |
Nuvalent Inc - Ordinary Shares - Class A
NUVL
|
BUY |
$132.00
Est. +34%
|
$98.17 | $123.99 |
Pending
|
$123.96
+26.3%
|
| Jul 15, 2025 |
Syndax Pharmaceuticals Inc
SNDX
|
BUY |
$35.00
Est. +257%
|
$9.80 | $25.58 |
Miss
|
$22.05
+125.0%
|
| May 16, 2025 |
Iovance Biotherapeutics Inc
IOVA
|
BUY |
$2.00
Est. +20%
|
$1.66 | $5.63 |
Target Met
|
$5.17
+211.4%
|
| Oct 24, 2024 |
Iovance Biotherapeutics Inc
IOVA
|
BUY |
$17.00
Est. +73%
|
$9.82 | $12.50 |
Miss
|
$5.17
-47.4%
|
| Oct 24, 2024 |
Kura Oncology Inc
KURA
|
BUY |
$27.00
Est. +59%
|
$17.02 | $19.73 |
Miss
|
$10.54
-38.1%
|
| Oct 24, 2024 |
Syndax Pharmaceuticals Inc
SNDX
|
BUY |
$37.00
Est. +100%
|
$18.54 | $22.50 |
Miss
|
$22.05
+18.9%
|
| Oct 24, 2024 |
Nuvalent Inc - Ordinary Shares - Class A
NUVL
|
BUY |
$100.00
Est. +7%
|
$93.71 | $99.94 |
Bullseye Hit (±1%)
|
$123.96
+32.3%
|
| Oct 24, 2024 |
Nurix Therapeutics Inc
NRIX
|
BUY |
$35.00
Est. +41%
|
$24.78 | $29.56 |
Miss
|
$23.60
-4.8%
|
| Oct 24, 2024 |
Blueprint Medicines Corp
BPMC
|
BUY |
$88.00
Est. +4%
|
$84.40 | $129.65 |
Target Met
|
$129.46
+53.4%
|
| Oct 24, 2024 |
Ideaya Biosciences Inc
IDYA
|
BUY |
$50.00
Est. +69%
|
$29.50 | $32.67 |
Miss
|
$35.00
+18.6%
|
| Oct 24, 2024 |
Cg Oncology Inc.
CGON
|
BUY |
$60.00
Est. +68%
|
$35.61 | $45.56 |
Miss
|
$69.31
+94.6%
|
| Oct 24, 2024 |
Merus N.V
MRUS
|
BUY |
$72.00
Est. +38%
|
$52.31 | $95.06 |
Target Met
|
$90.00
+72.1%
|
| Oct 24, 2024 |
Janux Therapeutics Inc
JANX
|
BUY |
$69.00
Est. +33%
|
$51.75 | $71.71 |
Target Met
|
$15.62
-69.8%
|
| Oct 24, 2024 |
Immunocore Holdings plc - ADR
IMCR
|
SELL |
$24.00
Est. +25%
|
$32.02 | $23.15 (Low) |
Target Met
|
$35.54
-11.0%
|
| Oct 24, 2024 |
Perspective Therapeutics Inc
CATX
|
BUY |
$20.00
Est. +71%
|
$11.69 | $12.90 |
Miss
|
$2.97
-74.6%
|
| Oct 24, 2024 |
Cullinan Therapeutics Inc
CGEM
|
BUY |
$30.00
Est. +92%
|
$15.61 | $17.50 |
Miss
|
$17.65
+13.1%
|